EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information
Scientific recommendations on classification of advanced therapy medicinal products
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 18, Status: Authorised
Appendix 1: Acceptable intakes established for N-nitrosamines
Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised
The European Journal of Case Reports in Internal Medicine (EJCRIM) - official journal of the European Federation of Internal Medicine (EFIM) entirely dedicated to case reports - is seeking a Deputy Editor to join its editorial team.
This role is an opportunity for an experienced internal medicine physician to contribute to the strategic direction and editorial leadership of the journal, helping to shape the dissemination of high-quality clinical case reports.
Read more information here
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0364/2022